A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function

Journal of Hypertension

Volumn 27, Issue 3, 2009, Pages 508-516

  Ueno, Takahiro ^a   Fukuda, Noboru ^a   Tsunemi, Akiko ^b   Yao, En Hui ^a   Matsuda, Hiroyuki ^b   Tahira, Kazunobu ^a   Matsumoto, Taro ^a   Matsumoto, Koichi ^a   Matsumoto, Yoshiaki ^b,d   Nagase, Hiroki ^b   Sugiyama, Hiroshi ^a   Sawamura, Tatsuya ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c Kyoto Graduate School of Medicine   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Apoptosis; Endothelial cell function; Lectin like oxidized lowdensity lipoprotein receptor 1; Pyrrole imidazole polyamide

Indexed keywords

COMPLEMENTARY DNA; DOUBLE STRANDED DNA; HYDROGEN PEROXIDE; IMIDAZOLE DERIVATIVE; LUCIFERASE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PHORBOL 13 ACETATE 12 MYRISTATE; POLYAMIDE; PYRROLE DERIVATIVE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ASSAY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RECEPTOR GENE; SYNTHESIS;

EID: 67649530349     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283207fe1     Document Type: Article

References (38)

1. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62.
2. Hackett D, Davies G, Maseri A. Preexisting coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988; 9:1317-1323.
3. Maher VM. Coronary atherosclerosis stabilization: an achievable goal. Atherosclerosis 1995; 118 (Suppl):S91-S101.
4. Parthasarathy S, Fong LG, Quinn MT, Steinberg D. Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification. Eur Heart J 1990; 11 (Suppl E):83-87.
5. Steinberg D. Oxidative modification of LDL in the pathogenesis of atherosclerosis. Am J Geriatr Cardiol 1993; 2:38-41.
6. Steinberg D, Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95:1062-1071.
7. Hamdheydari L, Christov A, Ottman T, Hensley K, Grammas P. Oxidized LDLs affect nitric oxide and radical generation in brain endothelial cells. Biochem Biophys Res Commun 2003; 311:486-490.
8. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386:73-77.
9. Hoshikawa H, Sawamura T, Kakutani M, Aoyama T, Nakamura T, Masaki T. High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1). Biochem Biophys Res Commun 1998; 245:841- 846.
10. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, Kita T, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/ apoptotic cells in endothelial cells. Proc Natl Acad Sci USA 1998; 95:9535-9540.
11. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 2001; 276:13750-13755.
12. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 1999; 84:1043-1049.
13. Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K, et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999; 100:899-902.
14. Honjo M, Nakamura K, Yamashiro K, Kiryu J, Tanihara H, McEvoy LM, et al. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci USA 2003; 100:1274-1279.
15. Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther 2002; 302:601-605.
16. Mrksich M, Wade WS, Dwyer TJ, Geierstanger BH, Wemmer DE, Dervan PB. Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. Proc Natl Acad Sci USA 1992; 89:7586-7590.
17. Geierstanger BH, Mrksich M, Dervan PB, Wemmer DE. Design of a G.C-specific DNA minor groove-binding peptide. Science 1994; 266:646-650.
18. Trauger JW, Baird EE, Dervan PB. Recognition of DNAby designed ligands at subnanomolar concentrations. Nature 1996; 382:559-561.
19. Trauger JW, Baird EE, Dervan PB. Extended hairpin polyamide motif for sequence-specific recognition in the minor groove of DNA. Chem Biol 1996; 3:369-377.
20. Pelton JG, Wemmer DE. Structural characterization of a 2:1 distamycin A.d(CGCAAATTGGC) complex by two-dimensional NMR. Proc Natl Acad Sci USA 1989; 86:5723-5727.
21. White S, Baird EE, Dervan PB. Effects of the A.T/T.A degeneracy of pyrrole-imidazole polyamide recognition in the minor groove of DNA. Biochemistry 1996; 35:12532-12537.
22. Chiang SY, Burli RW, Benz CC, Gawron L, Scott GK, Dervan PB, et al. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. J Biol Chem 2000; 275:24246-24254.
23. Gottesfeld JM, Belitsky JM, Melander C, Dervan PB, Luger K. Blocking transcription through a nucleosome with synthetic DNA ligands. J Mol Biol 2002; 321:249-263.
24. Nguyen-Hackley DH, Ramm E, Taylor CM, Joung JK, Dervan PB, Pabo CO. Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands. Biochemistry 2004; 43:3880-3890.
25. Lai YM, Fukuda N, Ueno T, Matsuda H, Saito S, Matsumoto K, et al. Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene. J Pharmacol Exp Ther 2005; 315:571-575.
26. Matsuda H, Fukuda N, Ueno T, Tahira Y, Ayame H, Zhang W, et al. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. J Am Soc Nephrol 2006; 17:422-432.
27. Chen H, Li D, Sawamura T, Inoue K, Mehta JL. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun 2000; 276:1100-1104.
28. Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, et al. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. Atherosclerosis 2006; 187:92-100.
29. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 2002; 39:1429-1435.
30. Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 1999; 339 (Pt 1):177-184.
31. TahiraY,FukudaN,EndoM, SuzukiR, IkedaY, Takagi H,etal. Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. Hypertens Res 2002; 25:911-918.
32. Harger JW, Dinman JD. An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. RNA 2003; 9:1019-1024.
33. Bando T, Narita A, Saito I, Sugiyama H. Molecular design of a pyrrole-imidazole hairpin polyamide for effective DNA alkylation. Chemistry 2002; 8:4781-4790.
34. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007; 100:1634-1642.
35. Hinagata J, Kakutani M, Fujii T, Naruko T, Inoue N, Fujita Y, et al. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res 2006; 69:263-271.
36. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 2008; 118:75-83.
37. Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul Pharmacol 2007; 47:1-9.
38. Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability - analysis in hypercholesterolemic rabbits. Atherosclerosis 2007; 195:48-56.